Identifying Innate Resistance Hotspots for SARS-CoV-2 Antivirals Using In Silico Protein Techniques

The development and approval of antivirals against SARS-CoV-2 has further equipped clinicians with treatment strategies against the COVID-19 pandemic, reducing deaths post-infection. Extensive clinical use of antivirals, however, can impart additional selective pressure, leading to the emergence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Portelli, Stephanie, Heaton, Ruby, Ascher, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531314/
https://www.ncbi.nlm.nih.gov/pubmed/37761839
http://dx.doi.org/10.3390/genes14091699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531314/
https://www.ncbi.nlm.nih.gov/pubmed/37761839
http://dx.doi.org/10.3390/genes14091699

Ejemplares similares